ArticleCurrent oncology (Toronto, Ont.)2026
Claudin 18.2 Expression and Outcomes of First-Line Chemoimmunotherapy in HER2-Negative Gastric or Gastroesophageal Junction Cancer: A Single-Center Retrospective Study.
Run Bao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.